Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,762 total articles
CaliberCos Inc. (Nasdaq: CWD), a diversified real estate and digital asset management platform, reported a platform net loss of $7.7 million for Q4 2025, an improvement from last year, driven by asset management revenues of $4.0 million and impacted by unrealized losses in digital assets. Full-year 2025 platform revenue declined to $15.2 million fr…
ARMOUR Residential REIT, Inc. has provided guidance for its April 2026 dividend on its common stock at $0.24 per share. The dividend will be paid on April 29, 2026, to holders of record as of April 15, 2026. The company maintains its tax status as a REIT and emphasizes that actual dividends are subject to board discretion based on company performan…
Colombier Acquisition Corp. III announced that starting March 27, 2026, holders of its previously issued units from the IPO can opt to trade Class A ordinary shares and warrants separately on the NYSE under the tickers CLBR and CLBR WS, respectively. Units not separated will continue trading under CLBR U. The company is a blank check firm seeking f…
Omega Flex, Inc., listed on NASDAQ under ticker OFLX, announced a regular quarterly dividend of $0.34 per share for the first quarter of 2026. The dividend will be payable on April 21, 2026 to shareholders of record on April 9, 2026. The company's Board of Directors will continue to evaluate quarterly dividend amounts based on financial performance…
Lifeward Ltd. has completed its strategic partnership with Oramed Pharmaceuticals, acquiring Oramed's clinical-stage Protein Oral Delivery technology and gaining access to up to $47 million in capital. This partnership diversifies Lifeward's biomedical innovation portfolio and positions the company on a clear path to profitability, while also leadi…
Regeneron Pharmaceuticals, a leading biotechnology company, announced it will report its Q1 2026 financial and operating results on April 29, 2026, prior to U.S. market open. A conference call and webcast will be held to discuss these results.
Workhorse Group Inc. announced a new configuration of its W56 step van featuring a 140 kWh battery, designed specifically for urban last-mile delivery routes. The new model offers a 100-mile range at a lower entry price starting at $169,000, responding to customer demand for cost-effective EVs to diversify fleets and hedge against rising fuel costs…
Prairie Operating Co., a US-based independent energy company focused on oil and natural gas development in the Denver-Julesburg Basin, announced that the anniversary warrant issuance date tied to its Series F Convertible Preferred Stock has been extended from March 26, 2026 to April 7, 2026. This extension allows additional time for ongoing discuss…
Rigetti Computing announced plans to invest up to $100 million in the UK to accelerate quantum computing development, aiming to deploy a quantum computer with over 1,000 qubits within 3 to 4 years. This marks Rigetti's first major investment outside the US and aligns with the UK government's £2 billion quantum computing initiative. The company high…
Minerva Neurosciences announced data from its open-label safety trial evaluating the co-administration of roluperidone and olanzapine. The study showed no significant safety, pharmacokinetic, or pharmacodynamic issues, supporting continued development. The company is now enrolling a confirmatory Phase 3 trial with topline data expected in the secon…
Firefly Aerospace, a U.S.-based space and defense technology company, supported Lockheed Martin and the U.S. Space Force in the VICTUS DIEM exercises focusing on rapid spacecraft processing and launch capabilities. The exercises demonstrated spacecraft arrival, integration, and launch operations within stringent timelines under simulated threat con…
Outlook Therapeutics, a U.S.-based biopharmaceutical company focused on ophthalmic treatments for retina diseases, successfully closed a $5.0 million public offering by selling 20 million common shares with accompanying warrants. The funds raised will primarily support working capital and general corporate activities. The company is developing LYTE…
WidePoint Corporation reported fourth quarter and full year 2025 results showing revenue growth compared to the prior year. The company achieved its 34th consecutive quarter of positive adjusted EBITDA and 9th quarter of positive free cash flow. Significant contract wins and backlog totaling over $220 million position WidePoint for future growth, p…
Noodles & Company reported modest revenue growth in 2025 alongside significant improvements in comparable restaurant sales and adjusted EBITDA in Q4 2025. The company highlighted strong momentum entering 2026 with comparable sales growth exceeding 9% and forecasts robust financial performance and operational efficiencies, despite ongoing net losses…
Artelo Biosciences announces strategic expansion of ART27.13 development targeting preservation of muscle mass in patients receiving GLP-1 receptor agonist therapy. Supported by clinical and preclinical data, patent filing, and initiation of new studies, the company aims to position ART27.13 as a differentiated companion therapy in the fast-growing…
Stran & Company, Inc. reported strong fiscal 2025 financial results with $116.2 million in sales, a 40.6% increase from 2024, and positive EBITDA of $0.2 million compared to a loss in the prior year. Revenue growth was driven by 12.9% organic growth in the core promotional products segment and a significant sales increase from the acquired Gander G…
Burke & Herbert Financial Services Corp. and LINKBANCORP, Inc., both Nasdaq-listed US community bank holding companies, have received shareholder approval to merge, with Burke & Herbert as the surviving entity. The merger aims to enhance financial solutions across multiple states in the Mid-Atlantic region and is subject to regulatory approvals and…
SeaStar Medical reported 2025 financial results highlighting significant progress in clinical trials for its Selective Cytopheretic Device (SCD) therapy for Acute Kidney Injury (AKI), expanding the QUELIMMUNE therapy's adoption in top pediatric hospitals, and preparing for FDA approvals. The company achieved over 50% enrollment in the pivotal NEUTR…
Parsons Corporation has been appointed lead designer for the $389 million design-build project to improve I-64 Hampton Roads Express Lanes in Virginia. This initiative aims to fill a critical gap in the existing toll lane system, enhance travel reliability, reduce congestion, and complete a continuous 45-mile regional express lane network through N…
Casella Waste Systems, a regional solid waste, recycling, and resource management company, announced that its management will present at the upcoming Gabelli Funds 12th Annual Waste and Sustainability Symposium on April 9, 2026. Presentation materials will be made available on the company's investor website prior to the event.
Equillium, a clinical-stage biotech focused on immunobiology therapies for autoimmune and inflammatory diseases, reported Q4 and full year 2025 financial results. The company completed two financings totaling $85 million, bolstering cash reserves to $30.3 million as of year-end plus $35 million raised in March 2026, expected to fund operations thro…
Celcuity Inc. announced the FDA acceptance and priority review of its New Drug Application for gedatolisib targeting HR+/HER2-/PIK3CA wild-type advanced breast cancer with a PDUFA date of July 17, 2026. Positive Phase 3 trial results from the PIK3CA WT cohort showed significant improvement in progression-free survival and well-being measures. Topli…
Journey Medical Corporation reported a 10% revenue increase in FY2025 to $61.9 million, fueled by the successful launch and commercialization of Emrosi™, a treatment for rosacea. The company improved gross margins and achieved an adjusted EBITDA of $2.9 million, signaling financial strengthening despite a net loss of $11.4 million. Emrosi™ expanded…
Colliers International Group Inc. completed a private placement of C$550 million (approx. US$400 million) in 4.73% fixed rate senior unsecured notes due 2033. The funds will be used primarily for general corporate purposes, including repayment of borrowings under their revolving credit facility, enhancing financial flexibility to support long-term …
Cibus, Inc., an ag-tech company specializing in gene editing for plant traits, announced a planned underwritten public offering of Class A common stock and pre-funded warrants. The company intends to use the net proceeds for working capital and to advance its weed management traits in rice. The offering is subject to market conditions and includes …
